Impacts of the COVID-19 pandemic on sepsis incidence, etiology and hospitalization costs in France: a retrospective observational study

Marie Al Rahmoun, Alexandre Sabaté-Elabbadi, Didier Guillemot, Christian Brun-Buisson, Laurence Watier
{"title":"Impacts of the COVID-19 pandemic on sepsis incidence, etiology and hospitalization costs in France: a retrospective observational study","authors":"Marie Al Rahmoun, Alexandre Sabaté-Elabbadi, Didier Guillemot, Christian Brun-Buisson, Laurence Watier","doi":"10.1101/2024.09.11.24311990","DOIUrl":null,"url":null,"abstract":"Importance Sepsis is a serious medical condition that causes long-term morbidity and high mortality, annually affecting millions of people worldwide. The COVID-19 pandemic may have impacted its burden. Objective To estimate the impact of the COVID-19 pandemic on sepsis incidence, etiology and associated hospitalization costs in metropolitan France.\nDesign, Setting and Participants This retrospective observational study used data drawn from a cohort of hospitalized sepsis patients in France s national healthcare database. Sepsis was identified through both explicit ICD-10 codes (E-sepsis) and implicit codes (I-sepsis). Participants included all patients aged 15 years or older hospitalized with E-sepsis or I-sepsis in metropolitan France between January 1, 2018, and December 31, 2022. Main outcomes and measures Patient and hospital stay characteristics were described by sepsis type (E-sepsis, I-sepsis) and overall. The distribution of sepsis etiology was estimated for each year. Annual incidence rates were estimated overall and by sepsis type and etiology. Total and median per-stay hospitalization costs were calculated.\nResults The total age- and sex-standardized sepsis incidence rate per 100,000 increased slightly from 2018 (446, 95% CI 444.2 to 447.7) to 2020 (457, 95% CI 455.1 to 458.6) and then decreased in 2022 (382, 95% CI 380.2-383.7) (p <.0001). Incidence rates decreased for both E-sepsis and bacterial sepsis during the pandemic period, whereas I-sepsis incidence increased in 2020 and 2021, associated with a marked increase in viral sepsis and co-infections (p <.0001 for E- and I-sepsis). Viral sepsis represented about 10% of all sepsis cases during the pandemic, but only about 1% prior to the pandemic. Total sepsis-associated hospitalization costs and extra medication costs increased during the pandemic. Characteristics of patients and their hospital stays were overall stable over the five-year study period.\nConclusion and Relevance The COVID-19 pandemic led to a higher burden of sepsis in French hospitals and an increase in hospital stay costs. Critically, our study highlights the need for introducing explicit viral sepsis codes within the ICD-11 classification system and for achieving a consensus on its definition in order to robustly estimate sepsis incidence.","PeriodicalId":501071,"journal":{"name":"medRxiv - Epidemiology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"medRxiv - Epidemiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1101/2024.09.11.24311990","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Importance Sepsis is a serious medical condition that causes long-term morbidity and high mortality, annually affecting millions of people worldwide. The COVID-19 pandemic may have impacted its burden. Objective To estimate the impact of the COVID-19 pandemic on sepsis incidence, etiology and associated hospitalization costs in metropolitan France. Design, Setting and Participants This retrospective observational study used data drawn from a cohort of hospitalized sepsis patients in France s national healthcare database. Sepsis was identified through both explicit ICD-10 codes (E-sepsis) and implicit codes (I-sepsis). Participants included all patients aged 15 years or older hospitalized with E-sepsis or I-sepsis in metropolitan France between January 1, 2018, and December 31, 2022. Main outcomes and measures Patient and hospital stay characteristics were described by sepsis type (E-sepsis, I-sepsis) and overall. The distribution of sepsis etiology was estimated for each year. Annual incidence rates were estimated overall and by sepsis type and etiology. Total and median per-stay hospitalization costs were calculated. Results The total age- and sex-standardized sepsis incidence rate per 100,000 increased slightly from 2018 (446, 95% CI 444.2 to 447.7) to 2020 (457, 95% CI 455.1 to 458.6) and then decreased in 2022 (382, 95% CI 380.2-383.7) (p <.0001). Incidence rates decreased for both E-sepsis and bacterial sepsis during the pandemic period, whereas I-sepsis incidence increased in 2020 and 2021, associated with a marked increase in viral sepsis and co-infections (p <.0001 for E- and I-sepsis). Viral sepsis represented about 10% of all sepsis cases during the pandemic, but only about 1% prior to the pandemic. Total sepsis-associated hospitalization costs and extra medication costs increased during the pandemic. Characteristics of patients and their hospital stays were overall stable over the five-year study period. Conclusion and Relevance The COVID-19 pandemic led to a higher burden of sepsis in French hospitals and an increase in hospital stay costs. Critically, our study highlights the need for introducing explicit viral sepsis codes within the ICD-11 classification system and for achieving a consensus on its definition in order to robustly estimate sepsis incidence.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
COVID-19 大流行对法国败血症发病率、病因和住院费用的影响:一项回顾性观察研究
重要性 败血症是一种严重的内科疾病,会导致长期发病和高死亡率,每年影响全球数百万人。COVID-19 大流行可能对其负担产生了影响。目的 估计 COVID-19 大流行对法国大都市败血症发病率、病因和相关住院费用的影响。脓毒症通过明确的 ICD-10 编码(E-sepsis)和隐含编码(I-sepsis)进行识别。参与者包括 2018 年 1 月 1 日至 2022 年 12 月 31 日期间在法国本土因 E 败血症或 I 败血症住院的所有 15 岁或以上患者。主要结果和测量方法 根据败血症类型(E-败血症、I-败血症)和总体情况描述患者和住院特征。估计每年败血症病因的分布情况。按败血症类型和病因估算年度总体发病率。结果 每 10 万人中年龄和性别标准化败血症总发病率从 2018 年(446,95% CI 444.2 至 447.7)到 2020 年(457,95% CI 455.1 至 458.6)略有上升,然后在 2022 年有所下降(382,95% CI 380.2-383.7)(p <.0001)。在大流行期间,E-败血症和细菌性败血症的发病率均有所下降,而 I-败血症的发病率在 2020 年和 2021 年有所上升,这与病毒性败血症和合并感染的显著增加有关(E-败血症和 I-败血症的 p <.0001)。在大流行期间,病毒性败血症约占所有败血症病例的 10%,而在大流行之前仅占约 1%。在大流行期间,与败血症相关的住院总费用和额外药物费用都有所增加。在为期五年的研究期间,患者的特征和住院时间总体上保持稳定。重要的是,我们的研究强调,有必要在 ICD-11 分类系统中引入明确的病毒性败血症代码,并就其定义达成共识,以便有力地估计败血症的发病率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Climate Change and Malaria: A Call for Robust Analytics Female Infertility and Neurodevelopmental Disorders in Children: associations and evidence for familial confounding in Denmark Surveillance and control of neglected zoonotic diseases: methodological approaches to studying Rift Valley Fever, Crimean-Congo Haemorrhagic Fever and Brucellosis at the human-livestock-wildlife interface across diverse agricultural systems in Uganda Climate variation and serotype competition drive dengue outbreak dynamics in Singapore Leveraging an Online Dashboard to Inform on Infectious Disease Surveillance: A case Study of COVID-19 in Kenya.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1